Dai, Mingji

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Novel Anticancer Covalent Inhibitors of SHP2 Tyrosine Phosphatase Inspired from Natural Products
2023-DAI-70254
  1. Pharmaceuticals
  2. Biotechnology
Dai, Mingji
Catalysis-Enabled Concise Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester
2022-DAI-69694
  1. Biotechnology
  2. Medical/Health
Dai, Mingji
Amination Method for Medicinally Important Compounds
2021-DAI-69172
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Dai, Mingji
First-in-class Natural Products Targeting BRAT1 for Cancer
2021-DAI-69235
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Dai, Mingji
Single Step Method for Heterocycle Synthesis
2018-DAI-68010
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Dai, Mingji
New Target Identified for Cancer Therapy and Its Inhibitor
2018-DAI-68268
  1. Pharmaceuticals
Dai, Mingji
Compounds with Promising Antibacterial and Antifungal Activity for New Therapeutic Development
2017-DAI-67879
  1. Chemistry and Chemical Analysis
  2. Medical/Health
Dai, Mingji
Novel Aryl Isonitrile Antimicrobials Active Against Clinically Important Bacterial Strains
2015-DAI-67104
  1. Pharmaceuticals
  2. Medical/Health
Dai, Mingji
Neuropathic and Inflammatory Pain Therapeutics Targeting Adenylyl Cyclase
2015-DAI-67035
  1. Pharmaceuticals
Dai, Mingji

Details

Dr. Mingji Dai is the Asa Griggs Candler Professor of Chemistry at Emory University. Dr. Dai was formerly a professor of Organic Chemistry at Purdue University. Dr. Dai earned his B.S. from Peking University, his Ph.D. from Columbia University (dissertation awarded with distinction), and was a Postdoctoral Fellow at Harvard University and the Broad Institute. In 2016, Dr. Dai received the NSF CAREER Award. He is also the recipient of the 2015 Organic Letters Outstanding Author of the Year Lectureship Award, the Eli Lilly Grantee Award, and the Amgen Young Investigator Award. His research program works with both natural and unnatural molecules with particular potential for the treatment of cancer, CNS disorders, and infectious diseases. Dr. Dai also focuses on creating unconventional and diverse small molecule collections to target protein-protein interactions and exploring reversible and irreversible covalent small molecule protein interactions and their application in biology and drug discovery.

For additional information, visit Dr. Dai's Emory webpage: https://winshipcancer.emory.edu/bios/faculty/dai-mingji.html or the Dai Research Group website: https://dai.emorychem.science/